Krystal Biotech Inc (Krystal Biotech) is a gene therapy company that develops and commercializes treatments for dermatological diseases. The company’s pipeline includes B-VEC (bercolagene telserpavec) gene therapy, against dystrophic epidermolysis bullosa (DEB), KB105 therapy, targeting autosomal recessive congenital ichthyosis (ARCI), a genetic skin disease caused due to deficiency of TGM1 gene. Krystal Biotech also investigating KB301, to treat aesthetic skin conditions, KB104, against Netherton Syndrome, KB407, for the treatment of Junctional Epidermolysis Bullosa (JEB) and KB5XX, targeting chronic skin diseases. The company utilizes the skin TARgeted Delivery (STAR-D) platform to develop treatments for skin diseases. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania, the US.
Krystal Biotech Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline |
B-VEC (Bercolagene Telserpavec): |
Dystrophic Epidermolysis Bullosa (DEB) |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | New Products/Services | In July, the company expanded its R&D pipeline to oncology. |
2023 | Regulatory Approval | In May, the company announced that the US Food and Drug Administration (FDA) approved VYJUVEK (beremagene geperpavec-svdt) for the treatment of patients six months of age or older with dystrophic epidermolysis bullosa (DEB). |
2022 | Regulatory Approval | In August, the company announced the United States Food and Drug Administration (FDA) accepted its Investigational New Drug (IND) application to evaluate KB407 in a clinical trial for cystic fibrosis (CF). |
Competitor Comparison
Key Parameters | Krystal Biotech Inc | Adaptive Biotechnologies Corp | Abeona Therapeutics Inc | Castle Creek Biosciences Inc | Patagonia Pharmaceuticals LLC |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Pittsburgh | Seattle | Cleveland | Chester | Woodcliff Lake |
State/Province | Pennsylvania | Washington | Ohio | Pennsylvania | New Jersey |
No. of Employees | 229 | 709 | 57 | - | - |
Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Krish S. Krishnan | Chief Executive Officer; Chairman | Executive Board | 2016 | 58 |
Suma M. Krishnan | President - Research and Development; Director | Executive Board | 2022 | 58 |
Kathryn Romano | Chief Accounting Officer; Executive Vice President | Senior Management | 2020 | 42 |
Stéphane Paquette | Vice President - Business Development | Senior Management | - | - |
David Glynn | General Counsel | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward